Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4215673
Max Phase: Preclinical
Molecular Formula: C19H22N6O3S
Molecular Weight: 414.49
Molecule Type: Small molecule
Associated Items:
ID: ALA4215673
Max Phase: Preclinical
Molecular Formula: C19H22N6O3S
Molecular Weight: 414.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(CC(=O)N2CCN(c3nc(N)nc4scnc34)CC2)cc1OC
Standard InChI: InChI=1S/C19H22N6O3S/c1-27-13-4-3-12(9-14(13)28-2)10-15(26)24-5-7-25(8-6-24)17-16-18(29-11-21-16)23-19(20)22-17/h3-4,9,11H,5-8,10H2,1-2H3,(H2,20,22,23)
Standard InChI Key: YAHULMMYPWZTOQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 414.49 | Molecular Weight (Monoisotopic): 414.1474 | AlogP: 1.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 106.70 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.35 | CX LogP: 1.70 | CX LogD: 1.70 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.67 | Np Likeness Score: -1.13 |
1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R.. (2018) Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo., 61 (15): [PMID:29952567] [10.1021/acs.jmedchem.8b00521] |
Source(1):